PDCD1 and neoplasm: Moreover, the combined treatment of low-dose AA and anti-PD-L1 therapy reduced tumor growth more potently, compared with either treatment alone[108], implying that the tumor-killing effect of anti-PD-1/PD-L1 therapy may be correlated with ferroptosis.